What should be monitored hourly in a patient receiving magnesium sulfate?

Monitoring for signs of magnesium toxicity in a patient receiving magnesium sulfate is crucial because this medication is often used for conditions such as pre-eclampsia and eclampsia during pregnancy. Magnesium sulfate works as a central nervous system depressant and can help prevent seizures; however, it can also lead to toxicity if not properly managed.

Signs of magnesium toxicity include respiratory depression, diminished reflexes, hypotension, and altered mental status. Monitoring for these signs is essential to ensure the safety of both the mother and the fetus. Frequent assessment helps identify early signs of toxicity, allowing for prompt intervention such as adjusting the dosage or discontinuing the medication if necessary.

While other factors like blood pressure stability, fluid intake, and fetal heart rate are important in the overall management of a patient on magnesium sulfate, the direct concern for this medication's safety profile makes hourly monitoring for signs of magnesium toxicity a priority. This proactive approach helps mitigate potential risks associated with the treatment.